NCT00659295 - Observational Study to Evaluate the Safety of Levemir® in Diabetes | Biotech Hunter

Enrollment

51,170

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Start dose and frequency to be prescribed by the physician as a result of a normal clinical practice.

Trial Locations (13)

Novo Nordisk Investigational Site, Brussels

Novo Nordisk Investigational Site, Copenhagen S

Novo Nordisk Investigational Site, Prague

Novo Nordisk Investigational Site, Vouliagment

Novo Nordisk Investigational Site, Istanbul

Novo Nordisk Investigational Site, Kfar Saba

Novo Nordisk Investigational Site, Paris La Défense Cedex

Novo Nordisk Investigational Site, Espoo

Novo Nordisk Investigational Site, Dublin

Novo Nordisk Investigational Site, Rome

Novo Nordisk Investigational Site, Seoul

Novo Nordisk Investigational Site, Malmo

Novo Nordisk Investigational Site, Crawley